The Prospecive OBSERVational Munich Interventional MITRAl-Valve Registry

Recruiting

• Conditions: Tricuspid Valve Regurgitation; Mitral Valve Regurgitation; Mitral Valve Stenosis

• Registration Number: NCT04577248
• Lead Sponsor: Deutsches Herzzentrum Muenchen

Brief Summary

Prospective, single-center observational registry including all consecutive patients treated with transcatheter mitral or tricuspid valve therapy at the Deutsches Herzzentrum München, Germany.

Detailed Description

Long-term mortality after transcatheter mitral or tricuspid valve therapy

Study Timeline

• Study Start: 2020-09-15
• Status Verified: 2020-10
• Study First Submitted: 2020-10-01
• Study First Submitted QC: 2020-10-01
• Study First Posted: 2020-10-06
• Last Update Submitted: 2020-10-06
• Last Update Posted: 2020-10-08
• Primary Completion: 2030-12-31
• Study Completion: 2031-01-01

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 5000

Inclusion Criteria

• Age above 18 years and consentable
• Mitral Valve Regurgitation, Mitral Valve Stenosis, Tricuspid Valve Regurgitation, Tricuspid Stenosis
• Transcatheter mitral or tricuspid valve therapy considered best option by heart-team decision
• Written informed consent

Exclusion Criteria

• Patient's inability to fully cooperate with the protocol

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Long-term mortality	5 years	Long-term mortality

Trial Locations

Locations (1)

Deutsches Herzzentrum München des Freistaates Bayern, Technische Universität München; 🇩🇪 Munich, Bavaria, Germany